Skip to content
naulon

Not checkedNot checked for notices yet.

Antiphospholipid Syndrome Associated with Lung Embolism: A Case Report

Mohammed Alaidarous

Journal of Clinical and Diagnostic Research · 2018

doi:10.7860/jcdr/2018/35065.11476 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Antiphospholipid Syndrome (APS) is an autoimmune disease, where the immune system antibodies damage and attack the body’s own cells and tissues. Antibodies are proteins that protect the body against infections. Cells are damaged when these autoantibodies attack the phospholipids causing blood clots in the veins and arteries. An individual is diagnosed with APS if tested positive for autoantibodies and have a history of autoimmune diseases. Here, the case of a 33-year-old Saudi male is being reported, who was diagnosed with APS, treated with warfarin. The available knowledge about this disease and its relevance to the symptoms of the patient was also summerised.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.